Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]

Bettina K Andreassen,1 Helga H Hektoen,1 Karol Axcrona,2 Hilde Langseth,1 Jo S Stenehjem,1 Trude E Robsahm1 1Department of Research, Cancer Registry of Norway, Oslo, Norway; 2Department of Urology, Akershus University Hospital, Lørenskog, NorwayCorrespondence: Helga H Hektoen Email Helga....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Andreassen BK, Hektoen HH, Axcrona K, Langseth H, Stenehjem JS, Robsahm TE
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	cancer vitamin d mortality cancer death prospective study Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/0245058cf1934587be93993e101434df
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0245058cf1934587be93993e101434df
record_format	dspace
spelling	oai:doaj.org-article:0245058cf1934587be93993e101434df2021-11-09T18:40:34ZPrediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]1179-1349https://doaj.org/article/0245058cf1934587be93993e101434df2021-11-01T00:00:00Zhttps://www.dovepress.com/prediagnostic-serum-25-hydroxyvitamin-d-and-mortality-among-bladder--3-peer-reviewed-fulltext-article-CLEPhttps://doaj.org/toc/1179-1349Bettina K Andreassen,1 Helga H Hektoen,1 Karol Axcrona,2 Hilde Langseth,1 Jo S Stenehjem,1 Trude E Robsahm1 1Department of Research, Cancer Registry of Norway, Oslo, Norway; 2Department of Urology, Akershus University Hospital, Lørenskog, NorwayCorrespondence: Helga H Hektoen Email Helga.Helseth.Hektoen@kreftregisteret.no View the original paper by Dr Hektoen and colleagues This is in response to the Letter to the EditorAndreassen BKHektoen HHAxcrona KLangseth HStenehjem JSRobsahm TEDove Medical Pressarticlecancervitamin dmortalitycancer deathprospective studyInfectious and parasitic diseasesRC109-216ENClinical Epidemiology, Vol Volume 13, Pp 1061-1062 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	cancer vitamin d mortality cancer death prospective study Infectious and parasitic diseases RC109-216
spellingShingle	cancer vitamin d mortality cancer death prospective study Infectious and parasitic diseases RC109-216 Andreassen BK Hektoen HH Axcrona K Langseth H Stenehjem JS Robsahm TE Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
description	Bettina K Andreassen,1 Helga H Hektoen,1 Karol Axcrona,2 Hilde Langseth,1 Jo S Stenehjem,1 Trude E Robsahm1 1Department of Research, Cancer Registry of Norway, Oslo, Norway; 2Department of Urology, Akershus University Hospital, Lørenskog, NorwayCorrespondence: Helga H Hektoen Email Helga.Helseth.Hektoen@kreftregisteret.no View the original paper by Dr Hektoen and colleagues This is in response to the Letter to the Editor
format	article
author	Andreassen BK Hektoen HH Axcrona K Langseth H Stenehjem JS Robsahm TE
author_facet	Andreassen BK Hektoen HH Axcrona K Langseth H Stenehjem JS Robsahm TE
author_sort	Andreassen BK
title	Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_short	Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_full	Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_fullStr	Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_full_unstemmed	Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
title_sort	prediagnostic serum-25 hydroxyvitamin d and mortality among bladder cancer patients in the janus serum bank cohort: answer to a short comment [response to letter]
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/0245058cf1934587be93993e101434df
work_keys_str_mv	AT andreassenbk prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT hektoenhh prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT axcronak prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT langsethh prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT stenehjemjs prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT robsahmte prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter
_version_	1718440806790987776

Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]

Ejemplares similares